3863 results for «580»
3863 results
Obstructive and non-obstructive coronary disease in women
21 May 2019 – From EuroPCR 2019
Consult this session on obstructive and non-obstructive coronary disease in women to learn how to diagnose and manage non-obstructive coronary artery disease in women, thanks to a better understanding of gender-related aspects of coronary artery disease and responses to antiplatelet therapies.
Mitral and tricuspid interventions
20 May 2019 – From PCR Innovators Day 2019
Consult this session to learn more about the disruptive technologies developed by 4C Medical Technologies, Epygon and Tau-PNU, allowing a better treatment of mitral regurgitation.
LAA closure: overcoming anatomical barriers
21 May 2019 – From EuroPCR 2019
Consult this session to learn all about how to successfully overcome anatomical barriers during LAA closure procedure: to recognise the ones that challenge successful LAA implementation, understand how to choose the best device in order to overcome them and to learn specific procedural techniques for achieving success...
Bioresorbable scaffold: new data, new hope?
22 May 2019 – From EuroPCR 2019
Consult this session on bioresorbable scaffold (BRS) to learn about new data and clinical outcomes: FAMTOM II trial, BIOSOLVE-IV registry, and more!
An image is worth a 1,000 words
23 May 2019 – From EuroPCR 2019
Consult this session to discover some of the most interesting and puzzling images out of those submitted for EuroPCR 2019.
Dealing with coronary perforations in small arteries: coils, glue and more
22 May 2019 – From EuroPCR 2019
Consult this session to learn techniques and tools to efficiently deal with coronary perforations in small arteries, such as coils, glue and more!
Interventions for hypertension beyond the renal artery: a case-based discussion
23 May 2019 – From EuroPCR 2019
Consult this session to learn more about non-renal interventions for hypertension and the different device features, procedural steps and patient selection.
Left ventricular and systolic dimension determines anatomic suitability for transcatheter mitral valve implantation
25 Jun 2020 – From PCR e-Course 2020
A common exclusion for transcatheter mitral valve implantation (TMVI) is a small predicted neo-left ventricular outflow tract (LVOT). Simulation of the neoLVOT is time-consuming, requires multi-detector computerised tomography (MDCT), specialised software, and computer models of the prosthesis. Measurements that do not require neoLVOT simulation may provide...
New TMVI therapy to eliminate mitral regurgitation. Evidence and patient selection
26 Jun 2020 – From PCR e-Course 2020
Watch this video if you want to get the latest update on the first commercially available TMVI therapy (Tendyne), to learn about Tendyne clinical experience and how to identify the best candidates for this novel therapy.
Two-year outcomes of Tendyne Transcatheter Mitral Valve Implementation (TMVI) to treat symptomatic severe mitral regurgitation
Learn more about the 2-year outcomes of the first 100 patients treated as part of the Tendyne Expanded Clinical Study, and how the latest Tendyne clinical evidence may change the way the heart team treats mitral regurgitation.
Videos included on this page: the Hot Line presentation and...
Shaping care pathways for severe aortic stenosis patients in a COVID-19 context
Watch this roundtable discussion on the management of aortic stenosis in the context of the COVID-19 pandemic and how to readdress the treatment options and pathways to serve the needs of the patients in this difficult global crisis.
Portico FlexNav - Optimise TAVI outcomes from routine to complex cases
Watch this session if you want to learn how Portico enables you to achieve favorable haemodynamics and patient outcomes, to learn about the new Portico with FlexNav TAVI system and its deliverability and to learn the importance of looking ahead during transcatheter aortic valve implantation and...
Hot lines on Mitral interventions – part 1
25 Jun 2020 – From PCR e-Course 2020
Watch a series of Hot Lines on mitral interventions presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: EVOQUE replacement, Tendyne TMVI, CLASP, V-i-V and V-i-R, Tendyne MAC.
PCR e-Course Hot lines on TAVI – part 1
25 Jun 2020 – From PCR e-Course 2020
Watch a series of Hot Lines on TAVI presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: Evolut Low-Risk trial, MyVal-1 study, BASILICA vs. control, non-invasive ultrasound therapy, long-term outcomes after V-i-V.
PCR e-Course 2020 Late-Breaking Trials – part 1
26 Jun 2020 – From PCR e-Course 2020
Watch a series of Late-Breaking Trials presented during the PCR e-Course 2020 and see how they might have an impact on your practice:
- Crossover results from the RADIANCE-HTN SOLO trial
- DynamX Bioadaptor, a novel « uncaging » platform
- Two-stent vs. provisional for bifurcation PCI: the DEFINITION II trial
Hot lines on tricuspid interventions
Watch a series of Hot Lines on repair techniques for tricuspid regurgitation presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: Transferomal TTVR with EVOQUE, STTAR, TRILUMINATE.
PCR e-Course 2020 Hot lines: TAVI – part 2
26 Jun 2020 – From PCR e-Course 2020
Watch a series of Hot Lines on TAVI presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: PORTICO IDE, FlexNav Delivery System, FRANCE TAVI, BIVOLUT-X, VIVALL.
Mitral interventions - part 2: Global EXPAND registry
25 Jun 2020 – From PCR e-Course 2020
Watch this session to find out more on clip selection strategy and the safety and effectiveness of the MitraClip XTR System: Results and recommendations from the Global EXPAND Study.
This session was originally presented during PCR e-Course 2020.
Revascularisation strategies - PCR e-Course 2020 Hot lines
29 Jul 2020 – From PCR e-Course 2020
Watch a series of Hot Lines on revascularisation presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: ISIS II, REDUCER-I, RINCAL, SYNTAX score II 2020.
Hot line on PCI: high bleeding risk and DAPT - part 1
26 Jun 2020 – From PCR e-Course 2020
Watch a series of Hot Lines on high bleeding risk and DAPT presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: ARC-HBR, MODEL U-SES, Onyx ONE trials.
